Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Partnering is gene med future

Posted 4 May 2021 AM

Moving beyond traditional partnerships and working towards those that could improve Australia's healthcare system may also improve patient access to new gene and cell therapies, says Novartis' director of patient access Byron Muntz.

As a member of the newly established Industry Genomic Network Alliance (InGeNA), Muntz presented a new partnership model on the Alliance's first webinar, saying the industry has traditionally partnered in three main areas.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Pharma face-slapped for success
Reputation is finding itself under threat again
Approvals Action
Low dose Symdeko ticked
Along with one generic drug
Special Report
March 2021 PBAC outcomes
Less than a quarter of major new listing requests recommended